The chemical class designated as Srrp Activators encompasses a group of compounds that are identified by their ability to influence the activity of the serine/arginine-rich related protein, commonly abbreviated as Srrp. These activators operate by engaging in various cellular mechanisms that ultimately modulate the functionality of Srrp, particularly focusing on its role within the mRNA splicing process. Typically, these compounds can achieve this activation by targeting the phosphorylation processes that are critical for Srrp's role in spliceosome assembly and function. By altering the phosphorylation state of Srrp through inhibition or modification of kinase activity, such as Clk/Sty or SRPK, these activators can change the dynamics of how Srrp interacts with other splicing factors and components of the spliceosome. This modulation can lead to a cascade of effects on the splicing process, which is a pivotal aspect of gene expression and RNA maturation.
In addition to affecting phosphorylation, the Srrp activators can also exert influence over the spliceosome itself, which is a complex molecular machine responsible for the removal of introns from pre-mRNA. Some members of this chemical class can bind to the spliceosome, alter its composition, or affect its assembly, thereby producing an environment where the activity of Srrp is altered. By doing so, they can effectively change the pattern of mRNA splicing, dictating which exons are included or excluded in the final mRNA transcript. This level of control allows these activators to indirectly govern the repertoire of proteins produced within the cell, as splicing is intimately linked with the diversity of protein expression. The changes mediated by Srrp activators in splicing can have profound effects on cellular functions, as they can remodel the landscape of protein synthesis by facilitating or obstructing the inclusion of certain protein-coding sequences within mRNA.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 166866 | 192705-79-6 | sc-208154 | 5 mg | $300.00 | 1 | |
By inhibiting SR protein-specific kinase (SRPK), this compound could possibly activate Srrp by altering its phosphorylation and influencing splicing decisions. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
An inhibitor of the spliceosome complex, pladienolide B could possibly activate Srrp by impacting splicing factor assembly and affecting splicing regulation. | ||||||
Cdc2-Like Kinase Inhibitor, TG003 | 300801-52-9 | sc-202528 sc-202528A | 5 mg 25 mg | $139.00 $548.00 | 6 | |
TG003 is a Clk1 kinase inhibitor that could possibly activate Srrp by affecting the phosphorylation status of SR proteins, changing its role in mRNA splicing. | ||||||
Farnesyl thiosalicylic acid | 162520-00-5 | sc-205322 sc-205322A | 1 mg 5 mg | $61.00 $82.00 | 15 | |
This synthetic antitumor agent targets the splicing factor 3b complex and could possibly activate Srrp by altering the splicing process. | ||||||
RKI-1447 | 1342278-01-6 | sc-472590 | 1 mg | $330.00 | ||
This small molecule inhibits the U2 snRNP component of the spliceosome and could possibly activate Srrp by impacting alternative splicing regulation. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Although typically used as a diuretic, amiloride could possibly activate Srrp by interfering with certain cellular pathways and influencing the phosphorylation and activity of SR proteins like Srrp. | ||||||